CDK4 Cancer Research Results
CDK4, Cyclin-dependent kinase 4: Click to Expand ⟱
| Source: |
| Type: |
Cyclin-dependent kinase 4 (CDK4) is a key regulator of the cell cycle, particularly in the transition from the G1 phase to the S phase. Its expression and activity are often altered in various cancers, contributing to tumorigenesis.
CDK4 is frequently overexpressed in various cancers, and its expression levels can serve as a prognostic marker.
|
Melanoma, Melanoma Skin Cancer: Click to Expand ⟱
Melanoma is a rare form of skin cancer. It is more likely to invade nearby tissues and spread to other parts of the body than other types of skin cancer.
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
Melanoma, |
NA |
|
|
|
ATP↓, TumCCA↑, CDK2↓, CDK4↓, TumW↓,
| - |
in-vivo, |
Melanoma, |
NA |
|
|
|
- |
in-vitro, |
Melanoma, |
A431 |
|
|
|
*cl‑Casp8↑, *PARP↑, *P21↑, tumCV↓, TumCP↓, TumCCA↑, CycB/CCNB1↓, cycA1/CCNA1↓, CDK4↓, CDC2↓, P21↑, Apoptosis↑,
PKM2↓, ATF4↓, CDK4↓, COX2↓, MAPK↓,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
Mitochondria & Bioenergetics ⓘ
ATP↓, 1, CDC2↓, 1,
Core Metabolism/Glycolysis ⓘ
PKM2↓, 1,
Cell Death ⓘ
Apoptosis↑, 1, MAPK↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, CDK4↓, 3, cycA1/CCNA1↓, 1, CycB/CCNB1↓, 1, P21↑, 1, TumCCA↑, 2,
Migration ⓘ
TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
ATF4↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1,
Functional Outcomes ⓘ
TumW↓, 1,
Total Targets: 16
Pathway results for Effect on Normal Cells:
Cell Death ⓘ
cl‑Casp8↑, 1,
DNA Damage & Repair ⓘ
PARP↑, 1,
Cell Cycle & Senescence ⓘ
P21↑, 1,
Total Targets: 3
Scientific Paper Hit Count for: CDK4, Cyclin-dependent kinase 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:39 Cells:% prod#:% Target#:894 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page